Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.6 USD | +1.97% | +0.02% | -7.74% |
May. 14 | Transcript : The Clorox Company Presents at Goldman Sachs Global Staples Forum, May-14-2024 08:15 AM | |
May. 08 | Visa, PNC, Synchrony Among Companies Targeted in Cyberattack Campaign | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- With an expected P/E ratio at 72.34 and 22.23 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Household Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.74% | 16.34B | B+ | ||
+13.17% | 26.17B | B+ | ||
-11.61% | 7.33B | A- | ||
+5.96% | 5.98B | C | ||
-6.01% | 3.05B | C+ | ||
-3.55% | 2.22B | A- | ||
-15.86% | 1.77B | C+ | ||
+39.33% | 1.05B | - | - | |
+2.74% | 663M | - | ||
-26.53% | 450M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CLX Stock
- Ratings The Clorox Company